HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

Share :
Published: 11 Apr 2019
Views: 1998
Prof Shoba Navai - Baylor College of Medicine, Houston, USA

Prof Shoba Navai gives a press conference at AACR 2019 on the findings of a study showing the safety of the combination of chemotherapy and CAR T cells (targeting the protein HER-2) in patients with advanced sarcoma.